{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:42:46Z","timestamp":1793824966245,"version":"4.6.1"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T00:00:00Z","timestamp":1705449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["RF1NS133812"],"award-info":[{"award-number":["RF1NS133812"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01AG073323"],"award-info":[{"award-number":["U01AG073323"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R56AG074001"],"award-info":[{"award-number":["R56AG074001"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R21AG083003"],"award-info":[{"award-number":["R21AG083003"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG076448"],"award-info":[{"award-number":["R01AG076448"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG084250"],"award-info":[{"award-number":["R01AG084250"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG082211"],"award-info":[{"award-number":["RF1AG082211"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG082118"],"award-info":[{"award-number":["R01AG082118"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG066707"],"award-info":[{"award-number":["R01AG066707"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Structural Biology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.sbi.2024.102776","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T17:18:57Z","timestamp":1707412737000},"page":"102776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"special_numbering":"C","title":["Artificial intelligence for drug discovery and development in Alzheimer's disease"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5094-0936","authenticated-orcid":false,"given":"Yunguang","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feixiong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sbi.2024.102776_bib1","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/s41591-023-02505-2","article-title":"Emerging diagnostics and therapeutics for Alzheimer disease","volume":"29","author":"Self","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.sbi.2024.102776_bib2","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.sbi.2024.102776_sref3","article-title":"Alzheimer's disease drug development pipeline: 2023","volume":"9","author":"Cummings","year":"2023","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.sbi.2024.102776_bib4","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/med.21709","article-title":"Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing","volume":"40","author":"Fang","year":"2020","journal-title":"Med Res Rev"},{"key":"10.1016\/j.sbi.2024.102776_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1126\/science.abb8575","article-title":"Translating genetic risk of Alzheimer's disease into mechanistic insight and drug targets","volume":"370","author":"Sierksma","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.sbi.2024.102776_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104511","article-title":"The complex genetic architecture of Alzheimer's disease: novel insights and future directions","volume":"90","author":"Andrews","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.sbi.2024.102776_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13195-021-00951-z","article-title":"Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer's disease","volume":"14","author":"Fang","year":"2022","journal-title":"Alzheimer's Res Ther"},{"key":"10.1016\/j.sbi.2024.102776_sref8","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111717","article-title":"Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer's disease","volume":"41","author":"Xu","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.sbi.2024.102776_bib9","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/s43587-021-00138-z","article-title":"Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer's disease","volume":"1","author":"Fang","year":"2021","journal-title":"Nature Aging"},{"key":"10.1016\/j.sbi.2024.102776_bib10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41392-022-00994-0","article-title":"Artificial intelligence in cancer target identification and drug discovery","volume":"7","author":"You","year":"2022","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.sbi.2024.102776_bib11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.sbi.2024.102776_bib12","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.tips.2023.06.010","article-title":"AI-powered therapeutic target discovery","volume":"44","author":"Pun","year":"2023","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.sbi.2024.102776_bib13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2020.11.002","article-title":"Transformative network modeling of multi-omics data reveals detailed circuits, key regulators, and potential therapeutics for Alzheimer's disease","volume":"109","author":"Wang","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.sbi.2024.102776_bib14","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s42003-023-04791-5","article-title":"Predictive network analysis identifies JMJD6 and other potential key drivers in Alzheimer's disease","volume":"6","author":"Merchant","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.sbi.2024.102776_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/d41573-023-00158-x","article-title":"Genetic support for FDA-approved drugs over the past decade","author":"Rusina","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.sbi.2024.102776_bib16","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/ng.3916","article-title":"Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease","volume":"49","author":"Sims","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.sbi.2024.102776_bib17","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","article-title":"TREM2 is a receptor for \u03b2-amyloid that mediates microglial function","volume":"97","author":"Zhao","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.sbi.2024.102776_bib18","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.str.2021.06.010","article-title":"Selection and structural characterization of anti-TREM2 scFvs that reduce levels of shed ectodomain","volume":"29","author":"Szykowska","year":"2021","journal-title":"Structure"},{"key":"10.1016\/j.sbi.2024.102776_bib19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.chembiol.2021.07.014","article-title":"TREM2 is thyroid hormone regulated making the TREM2 pathway druggable with ligands for thyroid hormone receptor","volume":"29","author":"Ferrara","year":"2022","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.sbi.2024.102776_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","article-title":"APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches","volume":"20","author":"Serrano-Pozo","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.sbi.2024.102776_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neuron.2020.10.008","article-title":"Structural insights and links to Alzheimer disease pathogenesis","volume":"109","author":"Chen","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.sbi.2024.102776_bib22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3389\/fnmol.2019.00325","article-title":"Soluble epoxide hydrolase and brain cholesterol metabolism","volume":"12","author":"Domingues","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.sbi.2024.102776_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2023-331142","article-title":"Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer's disease","author":"Su","year":"2023","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.sbi.2024.102776_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb1206","article-title":"An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer's disease","volume":"12","author":"Ghosh","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.sbi.2024.102776_bib25","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1021\/acs.jmedchem.0c01886","article-title":"Movement to the clinic of soluble epoxide hydrolase inhibitor EC5026 as an analgesic for neuropathic pain and for use as a nonaddictive opioid alternative","volume":"64","author":"Hammock","year":"2021","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.sbi.2024.102776_sref26","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.immuni.2023.08.008","article-title":"Genetic\u00a0variants of phospholipase C-\u03b32 alter the phenotype\u00a0and function of microglia and confer differential risk for Alzheimer's disease","volume":"56","author":"Tsai","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.sbi.2024.102776_bib27","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41593-020-0650-6","article-title":"Alzheimer\u2019s-associated PLC\u03b32 is a signaling node required for both TREM2 function and the inflammatory response in human microglia","volume":"23","author":"Andreone","year":"2020","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.sbi.2024.102776_bib28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.molcel.2009.02.023","article-title":"Structural insights into formation of an active signaling complex between Rac and phospholipase C gamma 2","volume":"34","author":"Bunney","year":"2009","journal-title":"Mol Cell"},{"key":"10.1016\/j.sbi.2024.102776_bib29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00401-019-01994-1","article-title":"The role of ABCA7 in Alzheimer's disease: evidence from genomics, transcriptomics and methylomics","volume":"138","author":"De Roeck","year":"2019","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.sbi.2024.102776_bib30","doi-asserted-by":"crossref","first-page":"23790","DOI":"10.1073\/pnas.1908529116","article-title":"ABCA7 haplodeficiency disturbs microglial immune responses in the mouse brain","volume":"116","author":"Aikawa","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.sbi.2024.102776_bib31","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022111065","article-title":"Cryo-EM structures of human ABCA7 provide insights into its phospholipid translocation mechanisms","volume":"42","author":"Le","year":"2023","journal-title":"EMBO J"},{"key":"10.1016\/j.sbi.2024.102776_bib32","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/mp.2012.15","article-title":"High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease","volume":"17","author":"Pottier","year":"2012","journal-title":"Mol Psychiatr"},{"key":"10.1016\/j.sbi.2024.102776_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107719","article-title":"Depletion of the AD risk gene SORL1 selectively impairs neuronal endosomal traffic independent of amyloidogenic APP processing","volume":"31","author":"Knupp","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.sbi.2024.102776_bib34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nsmb.2954","article-title":"Structural basis for amyloidogenic peptide recognition by sorLA","volume":"22","author":"Kitago","year":"2015","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.sbi.2024.102776_bib35","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1474-4422(13)70276-X","article-title":"Targeting the \u03b2 secretase BACE1 for Alzheimer's disease therapy","volume":"13","author":"Yan","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.sbi.2024.102776_bib36","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neulet.2016.01.059","article-title":"Meta-analysis of BACE1 gene rs638405 polymorphism and the risk of Alzheimer's disease in Caucasion and Asian population","volume":"616","author":"Yu","year":"2016","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.sbi.2024.102776_bib37","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41582-021-00545-1","article-title":"The case for low-level BACE1 inhibition for the prevention of Alzheimer disease","volume":"17","author":"McDade","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.sbi.2024.102776_bib38","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1021\/acs.jmedchem.9b00309","article-title":"Structure-based design of selective \u03b2-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors: targeting the flap to gain selectivity over BACE2","volume":"62","author":"Fujimoto","year":"2019","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.sbi.2024.102776_bib39","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/eji.201646795","article-title":"Regulation of immune cell signaling by SHIP1: a phosphatase, scaffold protein, and potential therapeutic target","volume":"47","author":"Pauls","year":"2017","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.sbi.2024.102776_bib40","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1002\/alz.12821","article-title":"Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer's disease","volume":"19","author":"Castranio","year":"2023","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.sbi.2024.102776_sref41","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106375","article-title":"INPP5D modulates TREM2 loss-of-function phenotypes in a \u03b2-amyloidosis mouse model","volume":"26","author":"Iguchi","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.sbi.2024.102776_bib42","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1002\/cphg.105","article-title":"The AD knowledge portal: a repository for multi-omic data on Alzheimer's disease and aging","volume":"108","author":"Greenwood","year":"2020","journal-title":"Curr Protoc Hum Genet"},{"key":"10.1016\/j.sbi.2024.102776_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/alz.062285","article-title":"NIA genetics of Alzheimer's disease data storage site (NIAGADS): 2022 update","volume":"18","author":"Issen","year":"2022","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.sbi.2024.102776_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/alz.056284","article-title":"NCRAD Family Study and NIA-LOAD brain tissue: a NCRAD resource","volume":"17","author":"Nudelman","year":"2021","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.sbi.2024.102776_bib45","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13195-020-00760-w","article-title":"AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer's drug discovery","volume":"13","author":"Zhou","year":"2021","journal-title":"Alzheimer's Res Ther"},{"key":"10.1016\/j.sbi.2024.102776_bib46","article-title":"The Alzheimer's Cell Atlas (TACA): a single-cell molecular map for translational therapeutics accelerator in Alzheimer's disease","volume":"8","author":"Zhou","year":"2022","journal-title":"Alzheimer's Dementia: Translational Research & Clinical Interventions"},{"key":"10.1016\/j.sbi.2024.102776_bib47","article-title":"The worldwide Alzheimer's disease neuroimaging initiative: ADNI-3 updates and global perspectives","volume":"7","author":"Weber","year":"2021","journal-title":"Alzheimer's Dementia: Translational Research & Clinical Interventions"},{"key":"10.1016\/j.sbi.2024.102776_bib48","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1021\/acs.jcim.0c00675","article-title":"ZINC20\u2014a free ultralarge-scale chemical database for ligand discovery","volume":"60","author":"Irwin","year":"2020","journal-title":"J\u00a0Chem Inf Model"},{"key":"10.1016\/j.sbi.2024.102776_bib49","doi-asserted-by":"crossref","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","article-title":"PubChem substance and compound databases","volume":"44","author":"Kim","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.sbi.2024.102776_bib50","doi-asserted-by":"crossref","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","article-title":"ChEMBL: a large-scale bioactivity database for drug discovery","volume":"40","author":"Gaulton","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.sbi.2024.102776_bib51","doi-asserted-by":"crossref","first-page":"D668","DOI":"10.1093\/nar\/gkj067","article-title":"DrugBank: a comprehensive resource for in silico drug discovery and exploration","volume":"34","author":"Wishart","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.sbi.2024.102776_bib52","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1021\/jm030580l","article-title":"The PDBbind database: collection of binding affinities for Protein\u2212Ligand complexes with known three-dimensional structures","volume":"47","author":"Wang","year":"2004","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.sbi.2024.102776_bib53","doi-asserted-by":"crossref","first-page":"D198","DOI":"10.1093\/nar\/gkl999","article-title":"BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities","volume":"35","author":"Liu","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.sbi.2024.102776_bib54","doi-asserted-by":"crossref","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","article-title":"UniProt: the universal protein knowledgebase in 2023","volume":"51","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.sbi.2024.102776_bib55","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.sbi.2024.102776_bib56","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41586-023-05905-z","article-title":"Computational approaches streamlining drug discovery","volume":"616","author":"Sadybekov","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.sbi.2024.102776_sref57","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2022.100794","article-title":"Deep generative molecular design reshapes drug discovery","volume":"3","author":"Zeng","year":"2022","journal-title":"Cell Reports Medicine"},{"key":"10.1016\/j.sbi.2024.102776_sref58","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/s42256-022-00557-6","article-title":"Accurate prediction of molecular properties and drug targets\u00a0using a self-supervised image representation\u00a0learning framework","volume":"4","author":"Zeng","year":"2022","journal-title":"Nat Mach Intell"},{"key":"10.1016\/j.sbi.2024.102776_sref59","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/d41586-023-03172-6","article-title":"AI's potential to accelerate drug discovery needs a reality check","volume":"622","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.sbi.2024.102776_bib60","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s42256-020-0174-5","article-title":"Direct steering of de novo molecular generation with descriptor conditional recurrent neural networks","volume":"2","author":"Kotsias","year":"2020","journal-title":"Nat Mach Intell"},{"key":"10.1016\/j.sbi.2024.102776_bib61","first-page":"31","article-title":"Molecular generative model based on conditional variational autoencoder for de novo molecular design","volume":"10","author":"Lim","year":"2018","journal-title":"J\u00a0Cheminf"},{"key":"10.1016\/j.sbi.2024.102776_bib62","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aap7885","article-title":"Deep reinforcement learning for de novo drug design","volume":"4","author":"Popova","year":"2018","journal-title":"Sci Adv"},{"key":"10.1016\/j.sbi.2024.102776_bib63","article-title":"Graph networks for molecular design","volume":"2","author":"Mercado","year":"2021","journal-title":"Mach Learn: Sci Technol"},{"key":"10.1016\/j.sbi.2024.102776_bib64","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1021\/acs.molpharmaceut.9b00634","article-title":"From target to drug: generative modeling for the multimodal structure-based ligand design","volume":"16","author":"Skalic","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1016\/j.sbi.2024.102776_bib65","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1021\/acs.jcim.0c00599","article-title":"Generative network complex for the automated generation of drug-like molecules","volume":"60","author":"Gao","year":"2020","journal-title":"J\u00a0Chem Inf Model"},{"key":"10.1016\/j.sbi.2024.102776_bib66","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acs.jmedchem.2c00732","article-title":"RELATION: a deep generative model for structure-based de novo drug design","volume":"65","author":"Wang","year":"2022","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.sbi.2024.102776_bib67","first-page":"38","article-title":"Deep generative model for drug design from protein target sequence","volume":"15","author":"Chen","year":"2023","journal-title":"J\u00a0Cheminf"},{"key":"10.1016\/j.sbi.2024.102776_sref68","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btad157","article-title":"De novo drug design by iterative multiobjective deep reinforcement learning with graph-based molecular quality assessment","volume":"39","author":"Fang","year":"2023","journal-title":"Bioinformatics"},{"key":"10.1016\/j.sbi.2024.102776_bib69","first-page":"48","article-title":"Molecular de-novo design through deep reinforcement learning","volume":"9","author":"Olivecrona","year":"2017","journal-title":"J\u00a0Cheminf"},{"key":"10.1016\/j.sbi.2024.102776_sref70","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41596-021-00659-2","article-title":"Artificial intelligence\u2013enabled virtual screening of ultra-large chemical libraries with deep docking","volume":"17","author":"Gentile","year":"2022","journal-title":"Nat Protoc"},{"key":"10.1016\/j.sbi.2024.102776_bib71","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1021\/acs.jcim.9b00645","article-title":"Incorporating explicit water molecules and ligand conformation stability in machine-learning scoring functions","volume":"59","author":"Lu","year":"2019","journal-title":"J\u00a0Chem Inf Model"},{"key":"10.1016\/j.sbi.2024.102776_bib72","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J\u00a0Comput Chem"},{"key":"10.1016\/j.sbi.2024.102776_sref73","article-title":"Comprehensive characterization of multi-omic landscapes between gut-microbiota metabolites and the G-protein-coupled receptors in Alzheimer's disease","author":"Qiu","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.sbi.2024.102776_bib74","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41551-021-00819-5","article-title":"Amelioration of Alzheimer's disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow","volume":"6","author":"Xie","year":"2022","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.sbi.2024.102776_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2021.102327","article-title":"Graph neural network approaches for drug-target interactions","volume":"73","author":"Zhang","year":"2022","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.sbi.2024.102776_bib76","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s10489-021-02454-8","article-title":"KG-DTI: a knowledge graph based deep learning method for drug-target interaction predictions and Alzheimer's disease drug repositions","volume":"52","author":"Wang","year":"2022","journal-title":"Appl Intell"},{"key":"10.1016\/j.sbi.2024.102776_bib77","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.drudis.2022.02.023","article-title":"Compound\u2013protein interaction prediction by deep learning: databases, descriptors and models","volume":"27","author":"Du","year":"2022","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.sbi.2024.102776_bib78","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2220778120","article-title":"Contrastive learning in protein language space predicts interactions between drugs and protein targets","volume":"120","author":"Singh","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.sbi.2024.102776_bib79","first-page":"24","article-title":"Enabling a next-generation pipeline for interpretable prediction models in drug repurposing","author":"Yousefi","year":"2023","journal-title":"Briefings Bioinf"},{"key":"10.1016\/j.sbi.2024.102776_bib80","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1039\/D1SC06946B","article-title":"PIGNet: a physics-informed deep learning model toward generalized drug\u2013target interaction predictions","volume":"13","author":"Moon","year":"2022","journal-title":"Chem Sci"},{"key":"10.1016\/j.sbi.2024.102776_bib81","article-title":"Strategies for pre-training graph neural networks","author":"Hu","year":"2019","journal-title":"arXiv preprint arXiv:1905.12265"},{"key":"10.1016\/j.sbi.2024.102776_sref82","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1093\/bioinformatics\/btz418","article-title":"deepDR: a network-based deep learning approach to in silico drug repositioning","volume":"35","author":"Zeng","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.sbi.2024.102776_bib83","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1039\/C9SC04336E","article-title":"Target identification among known drugs by deep learning from heterogeneous networks","volume":"11","author":"Zeng","year":"2020","journal-title":"Chem Sci"},{"key":"10.1016\/j.sbi.2024.102776_bib84","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41467-021-21330-0","article-title":"Machine learning identifies candidates for drug repurposing in Alzheimer's disease","volume":"12","author":"Rodriguez","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.sbi.2024.102776_bib85","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1021\/ci300367a","article-title":"admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties","volume":"52","author":"Cheng","year":"2012","journal-title":"J\u00a0Chem Inf Model"},{"key":"10.1016\/j.sbi.2024.102776_bib86","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/bioinformatics\/bty707","article-title":"admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties","volume":"35","author":"Yang","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.sbi.2024.102776_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2020.107377","article-title":"A\u00a0Recurrent Neural Network model to predict blood\u2013brain barrier permeability","volume":"89","author":"Alsenan","year":"2020","journal-title":"Comput Biol Chem"},{"key":"10.1016\/j.sbi.2024.102776_bib88","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1002\/cmdc.201800533","article-title":"Silico prediction of blood\u2013brain barrier permeability of compounds by machine learning and resampling methods","volume":"13","author":"Wang","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.sbi.2024.102776_bib89","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1093\/bioinformatics\/btac211","article-title":"Relational graph convolutional networks for predicting blood\u2013brain barrier penetration of drug molecules","volume":"38","author":"Ding","year":"2022","journal-title":"Bioinformatics"},{"key":"10.1016\/j.sbi.2024.102776_bib90","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41698-020-0122-1","article-title":"Machine learning approaches to drug response prediction: challenges and recent progress","volume":"4","author":"Adam","year":"2020","journal-title":"npj Precis Oncol"},{"key":"10.1016\/j.sbi.2024.102776_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2023.110934","article-title":"Artificial intelligence-based diagnosis of Alzheimer's disease with brain MRI images","volume":"165","author":"Yao","year":"2023","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.sbi.2024.102776_bib92","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.1002\/alz.13390","article-title":"Artificial intelligence for biomarker discovery in Alzheimer's disease and dementia","volume":"19","author":"Winchester","year":"2023","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.sbi.2024.102776_bib93","doi-asserted-by":"crossref","first-page":"7106","DOI":"10.1021\/acs.jctc.1c00810","article-title":"Efficient exploration of chemical space with docking and deep learning","volume":"17","author":"Yang","year":"2021","journal-title":"J\u00a0Chem Theor Comput"},{"key":"10.1016\/j.sbi.2024.102776_bib94","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.inffus.2022.01.001","article-title":"Data harmonisation for information fusion in digital healthcare: a state-of-the-art systematic review, meta-analysis and future research directions","volume":"82","author":"Nan","year":"2022","journal-title":"Inf Fusion"},{"key":"10.1016\/j.sbi.2024.102776_bib95","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1021\/acs.jcim.2c01270","article-title":"Are deep learning structural models sufficiently accurate for virtual screening? Application of docking algorithms to AlphaFold2 predicted structures","volume":"63","author":"D\u00edaz-Rovira","year":"2023","journal-title":"J\u00a0Chem Inf Model"},{"key":"10.1016\/j.sbi.2024.102776_bib96","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41392-023-01381-z","article-title":"AlphaFold2 and its applications in the fields of biology and medicine","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.sbi.2024.102776_bib97","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1021\/acs.jctc.3c00214","article-title":"Artificial intelligence enhanced molecular simulations","volume":"19","author":"Zhang","year":"2023","journal-title":"J\u00a0Chem Theor Comput"},{"key":"10.1016\/j.sbi.2024.102776_sref98","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41587-023-01788-7","article-title":"Drug discovery companies are customizing ChatGPT: here's how","volume":"41","author":"Savage","year":"2023","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.sbi.2024.102776_bib99","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41587-023-01789-6","article-title":"How will generative AI disrupt data science in drug discovery?","volume":"41","author":"Vert","year":"2023","journal-title":"Nat Biotechnol"}],"container-title":["Current Opinion in Structural Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959440X24000034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959440X24000034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T19:33:51Z","timestamp":1779305631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959440X24000034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":99,"alternative-id":["S0959440X24000034"],"URL":"https:\/\/doi.org\/10.1016\/j.sbi.2024.102776","relation":{},"ISSN":["0959-440X"],"issn-type":[{"value":"0959-440X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artificial intelligence for drug discovery and development in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Structural Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sbi.2024.102776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102776"}}